vaccination-covid19-2nd-dose
{ "id": "551ef667-1402-4c92-ba34-a0bb88b998dc", "resourceType": "Immunization", "extension": [ { "url": "https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure", "valueCodeableConcept": { "coding": [ { "system": "http://snomed.info/sct", "code": "1324691000000104", "display": "Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine" } ] } } ], "identifier": [ { "system": "https://tools.ietf.org/html/rfc4122", "value": "7ec28d82-33bf-4e6d-a8de-91dcbc8d1802" } ], "status": "completed", "primarySource": false, "reportOrigin": { "text": "RR8 - LEEDS TEACHING HOSPITALS NHS TRUST" }, "occurrenceDateTime": "2021-02-23T13:00:08.476+00:00", "patient": { "reference": "Patient/1953684", "type": "Patient", "identifier": { "system": "https://fhir.nhs.uk/Id/nhs-number", "value": "9912003888" } }, "vaccineCode": { "coding": [ { "system": "http://snomed.info/sct", "code": "39114911000001105", "display": "COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" } ] }, "manufacturer": { "display": "DREAMLAND Pharmaceuticals Ltd" }, "lotNumber": "R04X", "protocolApplied": [ { "doseNumberPositiveInt": 2 } ] }
<Immunization xmlns="http://hl7.org/fhir"> <id value="551ef667-1402-4c92-ba34-a0bb88b998dc" /> <extension url="https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure"> <valueCodeableConcept> <coding> <system value="http://snomed.info/sct" /> <code value="1324691000000104" /> <display value="Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine" /> </coding> </valueCodeableConcept> </extension> <identifier> <system value="https://tools.ietf.org/html/rfc4122" /> <value value="7ec28d82-33bf-4e6d-a8de-91dcbc8d1802" /> </identifier> <status value="completed" /> <vaccineCode> <coding> <system value="http://snomed.info/sct" /> <code value="39114911000001105" /> <display value="COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" /> </coding> </vaccineCode> <patient> <reference value="Patient/1953684" /> <type value="Patient" /> <identifier> <system value="https://fhir.nhs.uk/Id/nhs-number" /> <value value="9912003888" /> </identifier> </patient> <occurrenceDateTime value="2021-02-23T13:00:08.476+00:00" /> <primarySource value="false" /> <reportOrigin> <text value="RR8 - LEEDS TEACHING HOSPITALS NHS TRUST" /> </reportOrigin> <manufacturer> <display value="DREAMLAND Pharmaceuticals Ltd" /> </manufacturer> <lotNumber value="R04X" /> <protocolApplied> <doseNumberPositiveInt value="2" /> </protocolApplied> </Immunization>
Immunization |
id : 551ef667-1402-4c92-ba34-a0bb88b998dc |
extension |
url : https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure |
value |
coding |
system : http://snomed.info/sct |
code : 1324691000000104 |
display : Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine |
identifier |
system : https://tools.ietf.org/html/rfc4122 |
value : 7ec28d82-33bf-4e6d-a8de-91dcbc8d1802 |
status : completed |
primarySource : False |
reportOrigin |
text : RR8 - LEEDS TEACHING HOSPITALS NHS TRUST |
occurrence : 2021-02-23T13:00:08.476+00:00 |
patient |
reference : Patient/1953684 |
type : Patient |
identifier |
system : https://fhir.nhs.uk/Id/nhs-number |
value : 9912003888 |
vaccineCode |
coding |
system : http://snomed.info/sct |
code : 39114911000001105 |
display : COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) |
manufacturer |
display : DREAMLAND Pharmaceuticals Ltd |
lotNumber : R04X |
protocolApplied |
doseNumber : 2 |